{"nct_id":"NCT00139737","title":"Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia","status":"COMPLETED","status_verified_date":"2021-03","start_date":"2002-03","start_date_type":null,"primary_completion_date":"2009-06","primary_completion_date_type":"ACTUAL","completion_date":"2009-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}